A one year and three months male child having Total Anomalous Pulmonary Venous Connection (TAPVC) presented at Ibrahim Cardiac Hospital and Research Institute with repeated cough, tachypnoea, fever, failure to thrive & diaphoresis particularly during feeding with a mild degree of cyanosis without any evidence of heart failure. He underwent successful rerouting of pulmonary veins to left atrium (LA). The procedure consisted of side to side wide anastomosis between confluence of pulmonary veins (CPV) and left atrium with the division and ligation of vertical vein at its opening to left innominate vein and closure of atrial septal defect (ASD). The patient is doing well without any symptoms at followup.
Introduction
Total Anomalous Pulmonary Venous Connection (TAPVC) is a rare congenital anomaly in which all four pulmonary veins have no direct communication with the left atrium. Instead they drain abnormally to the right atrium or to one of the systemic veins by way of an anomalous connection. 1,2 TAPVC accounts for 1% of all congenital heart defects and supracardiac variety accounts for 50% of all TAPVC patients. [1] [2] [3] Developmentaly, TAPVC occurs when the evaginated common pulmonary vein from the posterior surface of left atrium fails to fuse with the pulmonary venous plexus surrounding the lung buds. 1, 3 Depending on the drainage site of the pulmonary veins, the defects may be divided into (i) Supracardiac (50%)-when pulmonary veins open into left innominate vein and superior vena cava (SVC) (ii) Cardiac (28%)-when they open into coronary sinus (iii) Infracardiac (14%)-when they open into portal vein and (iv) Mixed (7%) variety. [1] [2] [3] For sustaining life, TAPVC requires some connection between right and left heart through PFO/ASD. 3 Two clinical patterns: (a) The obstructive type, characterized by an obstruction to pulmonary venous (PVO) return to the right atrium, leading to cyanosis with early pulmonary oedema and congestive cardiac failure. Death ensues within 3 months of life. 4 (b) The nonobstructive type (non-PVO)-characterized by delayed manifestation of symptoms with failure to thrive, growth retardation and recurrent respiratory tract infections. Death occurs in 70% of cases within a year. 4 PVO occurs most often with the infracardiac type and less often in the intracardiac type of TAPVC. With elevated pulmonary arterial pressure (PAP) an intracardiac shunt should be of right to left direction to induce more cyanosis. 4 Advent of 2-dimensional (2-D) color Doppler echocardiography, 5 CT angiography 6 and magnetic resonance imaging (MRI) have made TAPVC diagnosis easier. 7 
Clinical presentation
A one year and three months old male child was admitted to Ibrahim Cardiac Hospital and Research Institute for elective operation of TAPVC with past history of repeated respiratory tract infections, failure to thrive with mild cyanosis since birth. Cardiac auscultation revealed soft systolic murmur at 2 nd intercostal space in left parasternal area, S 2 is widely split and fixed with loud P 2 . The Electrocardiogram showed right atrio-ventricular hypertrophy. The Chest X-Ray demonstrated cardiomegaly with figure of eight appearance and increased pulmonary vascular markings (Fig. 1 Postoperative recovery was prolonged to some extent, due to left ventricular dysfunction that responded to ACEinhibitor. Routine follow up at 1 month and 3 months interval showed that the condition of the patient was satisfactory.
Discussion
The clinical symptoms and signs in TAPVC are variable depending on the pathological anatomy and the haemodynamics. Patients with obstructive type of TAPVC (with PVO) usually present with tachypnoea, tachycardia, difficulty feeding and cyanosis and even sudden death within the first 2-3 months after birth. 4, [8] [9] While those with non-obstructive type (without PVO) tend to present with failure to thrive, growth retardation, recurrent respiratory tract infections and heart failure later. Without proper surgery or treatment the prognosis of these patients is grim in the 1st year of life. 4, 10 TAPVC is either an isolated defect with small ASD or PFO or is a non isolated anomaly which is associated with various complex cardiac anomalies, such as Tetralogy of Fallot, common A-V canal defect, pulmonary stenosis or pulmonary atresia, mitral atresia, conotruncal anomalies, systemic venous anomalies or heterotaxy syndrome. 2, 4 With the advent of 2-D and color Doppler echocardiography, TAPVC can readily be diagnosed without any difficulty and the procedure is noninvasive and safe. Now a days, it is the modality of choice for diagnosis of complex congenital cardiac diseases. 4 The sensitivity and specificity for diagnosis by echocardiography including cross-sectional and color Doppler flow mapping have been reported to be up to 97% and 99% respectively.
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Diagnostic Cardiac Catheterization and angiocardiography is the gold standard for diagnosis of TAPVC. But the procedure being invasive and time consuming, the technique should be kept reserved for the patients who have coexisting complex heart lesions or mixed connection of pulmonary veins. 4 Now a days, CT angiogram and cardiac MRI are detailed imaging producer to correctly detect anomalous pulmonary venous channels in 98% of cases7. But these procedures are supplementary if echocardiography and angiography are inadequate. 4 The natural course of obstructive type of TAPVC is unfavorable because of progressing pulmonary artery hypertension and heart failure. 4 Our case had the features of non-obstructive type of TAPVC with severe pulmonary hypertension at the age of one year and three months with mild cyanosis and stunted growth. The only option of treatment was open heart repair of the anomaly to prevent progressive pulmonary hypertension and heart failure. That is why ligation and division of vertical vein and wide anastomosis between CPV and left atrium was done.
The estimated first year survival rate in patients with TAPVC is only 25% without treatment; 50% death occurs before 3 months of age and 80% death occurs before 1 year of age. 12 The operative mortality in patients under 1-year of age decreased significantly from 50% 13 in 1970s to 10-20% after 1970s. 14 However, some studies still report a higher operative mortality in TAPVC patients with PVO where surgery was done urgently 15 but more recent reports have described an early mortality rate of less than 10%. 2 In TAPVC without PVO surgical redirection can be performed within first month of life.
Hancock et al 16 reported that re-operation of post operative pulmonary veins stenosis in univentricular heart was 18% which was significantly high compared with 8% in the biventricular group. Improvement in surgical and suture techniques have brought improvement to anastomotic site stenosis but histologic anomaly in the form of an obliterative intimal fibrous hyperplasia near to the CPV and away from the anastomotic site of an individual pulmonary vein considerably increases the risk of postoperative individual vein stenosis. 17 The size of the pulmonary veins is an important determinant of outcome in patients with TAPVC. 2 
Conclusion
There is marked improvement in surgical results for isolated TAPVC with the improvement of preoperative diagnosis, treatment and surgical technique. However, surgical correction of TAPVC combined with univentricular heart still carries a high risk with mortality. In particular, concomitant palliation of the pulmonary artery at early age and low weight at the time of surgery are significant risk factors.
